Physician profile
Mark R Miles
NPI 1598792384
$1,873.93
in general payments reported to CMS, 2019-2025
9 companies · $49.45 in 2025
The $49.45 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.07 · 2022: $119 · 2023: $1,611 · 2024: $66.67 · 2025: $49.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,420 · Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,419.98 |
| Food and Beverage | $306.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,545.03 | 2023-2024 | Da Vinci Surgical System |
| Abbvie INC. | $147.77 | 2022-2023 | |
| Organon LLC | $46.07 | 2022-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $35.52 | 2021-2025 | Bridion |
| Astellas Pharma US INC | $31.54 | 2022-2023 | Myrbetriq |
| Sage Therapeutics, LLC | $29.48 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $13.24 | 2023 | Cologuard Collection Kit |
| Coopersurgical, INC. | $12.76 | 2022 | |
| Glaxosmithkline, LLC. | $12.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.